The autoimmune diseases manifested by production of autoantibodies: The autoantigens identified by random peptide library

Iranian Journal of Allergy, Asthma and Immunology

Volumn 7, Issue 3, 2008, Pages 115-131

  Jadali, Zohreh ^a   Sanati, Mohammad Hossein ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

Author keywords

Autoantigens; Autoimmune diseases; Random peptide library

Indexed keywords

AUTOANTIGEN; MONOCLONAL ANTIBODY; PEPTIDE LIBRARY; POLYCLONAL ANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN DETECTION; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CELIAC DISEASE; COGAN SYNDROME; CROHN DISEASE; CRYOGLOBULINEMIA; GRAVES DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NONHUMAN; PHAGE DISPLAY; PRIMARY BILIARY CIRRHOSIS; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VITILIGO;

ANIMALS; ANTIBODY FORMATION; ANTIGEN-ANTIBODY REACTIONS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; COMBINATORIAL CHEMISTRY TECHNIQUES; EPITOPES; HUMANS; IMMUNODOMINANT EPITOPES; PEPTIDE LIBRARY;

EID: 52249099708     PISSN: 17351502     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (95)

1. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228(4705):1315-7.
2. Devlin JJ, Panganiban LC, Devlin PE. Random peptide libraries: a source of specific protein binding molecules. Science 1990; 249(4967):404-6
3. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science. 1990; 249(4967):386-90.
4. Cwirla SE, Peters EA, Barrett RW, Dower WJ. Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci U S A 1990; 87(16):6378-82.
5. Smith GP, Petrenko VA. Phage Display. Chem Rev 1997; 97(2):391-410.
6. Zwick MB, Shen J, Scott JK. Phage-displayed peptide libraries. Curr Opin Biotechnol 1998; 9(4):427-36.
7. Cortese R, Monaci P, Nicosia A, Luzzago A, Felici F, Galfre G, et al. Identification of biologically active peptides using random libraries displayed on phage. Curr Opin Biotechnol 1995; 6(1):73-80.
8. Irving MB, Pan O, Scott JK. Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics. Curr Opin Chem Biol 2001; 5(3):314-24.
9. Hoess R, Brinkmann U, Handel T, Pastan I. Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene 1993;128(1):43-9.
10. Sergeeva A, Kolonin MG, Molldrem JJ, Pasqualini R, Arap W. Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 2006; 58(15):1622-54.
11. Manatunga V, Sanati H, Tan P, O'Brien PA. Maceration of plant tissue by fungi is inhibited by recombinant antipectinase antibodies. Eur J Plant Pathol 2005; 112:211-20.
12. Ding C, Yan J. Regulation of autoreactive B cells: checkpoints and activation. Arch Immunol Ther Exp (Warsz) 2007; 55(2):83-9.
13. Martin F, Chan AC. B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 2006; 24:467-96.
14. Tuscano JM, Harris GS, Tedder TF. B lymphocytes contribute to autoimmune disease pathogenesis: current trends and clinical implications. Autoimmun Rev 2003; 2(2):101-8.
15. Chan OT, Madaio MP, Shlomchik MJ. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev 1999; 169:107-21.
16. Murakami M, Honjo T. Transgenic mouse models for B-cell dominant autoimmune diseases. Curr Opin Immuno. 1997; 9(6):846-50.
17. Osman A, Uhlig H, Thamm B, Schneider-Mergener J, Mothes T.Use of the phage display technique for detection of epitopes recognized by polyclonal rabbit gliadin antibodies. FEBS Lett 1998; 433(01-2):103-7.
18. Osman AA, Gunnel T, Dietl A, Uhlig HH, Amin M, Fleckenstein B, et al. B cell epitopes of gliadin. Clin Exp Immunol 2000; 121(2):248-54.
19. Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S, et al. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med 2006; 3(9):e358.
20. Balass M, Heldman Y, Cabilly S, Givol D, Katchalski-Katzir E, Fuchs S. Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library.Proc Natl Acad Sci U S A 1993;90(22):10638-42.
21. Barchan D, Balass M, Souroujon MC, Katchalski-Katzir E, Fuchs S. Identification of epitopes within a highly immunogenic region of acetylcholine receptor by a phage epitope library.J Immunol 1995;155(9):4264-9.
22. Venkatesh N, Im SH, Balass M, Fuchs S, Katchalski-Katzir E. Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide. Proc Natl Acad Sci U S A 2000; 97(2):761-6.
23. Lunardi C, Bason C, Leandri M, Navone R, Lestani M, Millo E, et al. Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet 2002; 360(9337):915-21.
24. Bowditch RD, Tani P, Fong KC, McMillan R. Characterization of autoantigenic epitopes on platelet glycoprotein IIb/IIIa using random peptide libraries. Blood 1996; 88(12): 4579-84.
25. Gevorkian G, Manoutcharian K, Almagro JC, Govezensky T, Dominguez V. Identification of autoimmune thrombocytopenic purpura-related epitopes using phage-display peptide library. Clin Immunol Immunopathol 1998; 86(3):305-9.
26. Gevorkian G, Manoutcharian K, Govezensky T, Cano JA, Dominguez V, Santamaria H, et al. Identification of mimotopes of platelet autoantigens associated with autoimmune thrombocytopenic purpura. J Autoimmun 2000; 15(1):33-40.
27. Jensen-Jarolim E, Neumann C, Oberhuber G, Gscheidlinger R, Neuchrist C, Reinisch W, et al. Anti-Galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries. J Clin Immunol 2001; 21(5):348-56.
28. Saito H, Fukuda Y, Katsuragi K, Tanaka M, Satomi M, Shimoyama T, Saito T, Tachikawa T. Isolation of peptides useful for differential diagnosis of Crohn's disease and ulcerative colitis. Gut 2003; 52(4):535-40.
29. Mennuni C, Santini C, Dotta F, Farilla L, Di Mario U, Fierabracci A, et al. Selection of phage-displayed peptides mimicking type 1 diabetes-specific epitopes. J Autoimmun 1996; 9(3):431-6.
30. Mennuni C, Santini C, Lazzaro D, Dotta F, Farilla L, Fierabracci A, et al. Identification of a novel type 1 diabetes-specific epitope by screening phage libraries with sera from pre-diabetic patients. J Mol Biol 1997; 268(3):599-606.
31. Gregori S, Bono E, Gallazzi F, Hammer J, Harrison LC, Adorini L. The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library. Int Immunol 2000; 12(4):493-503.
32. Myers MA, Davies JM, Tong JC, Whisstock J, Scealy M, Mackay IR, Rowley MJ. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling. J Immunol 2000; 165(7):3830-8.
33. Fierabracci A, Biro PA, Yiangou Y, Mennuni C, Luzzago A, Ludvigsson J, et al. Osteopontin is an autoantigen of the somatostatin cells in human islets: identification by screening random peptide libraries with sera of patients with insulin-dependent diabetes mellitus. Vaccine 1999; 18(3-4):342-54.
34. Ola TO, Biro PA, Hawa MI, Ludvigsson J, Locatelli M, Puglisi MA, et al. Importin beta: a novel autoantigen in human autoimmunity identified by screening random peptide libraries on phage. J Autoimmun 2006; 26(3):197-207.
35. Devendra D, Galloway TS, Horton SJ, Wilkin TJ. Exploring the idiotypes of insulin antibodies as markers for remission in Type 1 diabetes. Diabet Med. 2004; 21(12):1316-24.
36. Devendra D, Franke B, Galloway TS, Horton SJ, Knip M, Wilkin TJ. Distinct idiotypes of insulin autoantibody in autoimmune polyendocrine syndrome type 2 and childhood onset type 1 diabetes. J Clin Endocrinol Metab 2004; 89(10):5266-70.
37. Dromey JA, Weenink SM, Peters GH, Endl J, Tighe PJ, Todd I, et al. Mapping of epitopes for autoantibodies to the type 1 diabetes autoantigen IA-2 by peptide phage display and molecular modeling: overlap of antibody and T cell determinants. J Immunol 2004;172(7):4084-90.
38. Navone R, Lunardi C, Gerli R, Tinazzi E, Peterlana D, Bason C, et al. Identification of tear lipocalin as a novel autoantigen target in Sjogren's syndrome. J Autoimmun 2005; 25(3):229-34.
39. Cha S, Leung PS, Van de Water J, Tsuneyama K, Joplin RE, Ansari AA, et al. Random phage mimotopes recognized by monoclonal antibodies against the pyruvate dehydrogenase complex-E2 (PDC-E2). Proc Natl Acad Sci U S A 1996; 93(20):10949-54.
40. Leung PS, Cha S, Joplin RE, Galperin C, Van de Water J, Ansari AA, et al. Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes. J Autoimmun 1996; 9(6):785-93.
41. Mackay IR, Davies JM, Rowley MJ. Towards the pathogenesis of autoimmune liver disease. J Autoimmun 1999; 13(1):163-9.
42. Rowley MJ, Scealy M, Whisstock JC, Jois JA, Wijeyewickrema LC, Mackay IR. Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display. J Immunol 2000; 164(6):3413-9.
43. Ikuno N, Scealy M, Davies JM, Whittingham SF, Omagari K, Mackay IR, et al. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display. Hepatology. 2001; 34(3):478-86.
44. Scealy M, Mackay IR, Rowley MJ. Amino acids critical for binding of autoantibody to an immunodominant conformational epitope of the pyruvate dehydrogenase complex subunit E2: identification by phage display and site-directed mutagenesis. Mol Immunol 2006; 43(3):745-53.
45. Beland K, Lapierre P, Marceau G, Alvarez F. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. J Autoimmun 2004; 22(2):159-66.
46. Mecchia M, Casato M, Tafi R, Filocamo G, Bonomo L, Fiorilli M, et al. Nonrheumatoid IgM in human hepatitis C virus-associated type II cryoglobulinemia recognize mimotopes of the CD4-like LAG-3 protein. J Immunol 1996;157(8):3727-36.
47. Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000; 6(10):1183-6.
48. Jadali Z, Eslami MB, Sanati MH, Mansouri P, Mahmoudi M, Maghsoudi N, et al. Identification of peptides specific for antibodies in vitiligo using a phage library. Clin Exp Dermatol 2005; 30(6):694-701.
49. Jadali1 Z, Eslami MB, Sanati MH, Mansoori P, Mahmoudi M, Maghsoodi N, et al. Identification of Hitherto Undefined B-Cell Epitopes by Antibodies in the Sera of Vitiligo Patients Using Phage-Display Peptide Library. Iran J Allergy Asthma Immunol 2003; 2(4):197-201.
50. Iverson GM, Jones DS, Marquis D, Linnik MD, Victoria EJ. A chemically defined, toleragen-based approach for targeting anti-beta2-glycoprotein I antibodies. Lupus 1998; 7(suppl 2):S166-9.
51. Koike T, Ichikawa K, Kasahara H, Atsumi T, Tsutsumi A, Matsuura E. Epitopes on beta2-GPI recognized by anticardiolipin antibodies. Lupus 1998; 7(Suppl 2):S14-7.
52. Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski-Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Natl Acad Sci U S A 1999; 96(9): 5164-8.
53. Visvanathan S, Scott JK, Hwang KK, Banares M, Grossman JM, Merrill JT, et al. Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome. Arthritis Rheum 2003; 48(3):737-45.
54. Kasahara H, Matsuura E, Kaihara K, Yamamoto D, Kobayashi K, Inagaki J, et al. Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies. Int Immunol 2005; 17(12): 1533-42.
55. Fischer C, Buschmann K, Blank M, Stachl A, Miesbach W, Shoenfeld Y, et al. Identification of a peptide mimicking the binding pattern of an antiphospholipid antibody. Immunobiology. 2006; 211(9): 695-9.
56. Byun CH, Park JY, Akamizu T, Chae CB. Identification of the peptides that inhibit the function of human monoclonal thyroid-stimulating antibodies from phage-displayed peptide library. J Clin Endocrinol Metab 2001; 86(7):3311-8.
57. Na CH, Lee MH, Cho BY, Chae CB. A method for identification of the peptides that bind to a clone of thyroid-stimulating antibodies in the serum of Graves' disease patients. J Clin Endocrinol Metab 2003; 88(4):1570-6.
58. Bresson D, Cerutti M, Devauchelle G, Pugniere M, Roquet F, Bes C, et al. Localization of the discontinuous immunodominant region recognized by human antithyroperoxidase autoantibodies in autoimmune thyroid diseases. J Biol Chem 2003; 278(11):9560-9.
59. Cook AD, Davies JM, Myers MA, Mackay IR, Rowley MJ. Mimotopes identified by phage display for the monoclonal antibody CII-C1 to type II collagen. J Autoimmun 1998; 11(3): 205-11.
60. Davies JM, Rowley MJ, MacKay IR. Phagotopes derived by antibody screening of phage-displayed random peptide libraries vary in immunoreactivity: studies using an exemplary monoclonal antibody, CII-C1, to type II collagen. Immunol Cell Biol 1999; 77(6): 483-90.
61. Davies JM, Mackay IR, Rowley MJ. Rheumatoid arthritis sera react with a phage-displayed peptide selected by a monoclonal antibody to type II collagen that has homology to EBNA-1. Autoimmunity. 1999; 30: 53-9.
62. Xu Y, Ramsland PA, Davies JM, Scealy M, Nandakumar KS, Holmdahl R, et al. Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry. Mol Immunol 2004; 41(4):411-9.
63. Dybwad A, Forre O, Kjeldsen-Kragh J, Natvig JB, Sioud M. Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library. Eur J Immunol 1993; 23(12):3189-93.
64. Dybwad A, Forre O, Natvig JB, Sioud M. Structural characterization of peptides that bind synovial fluid antibodies from RA patients: a novel strategy for identification of disease-related epitopes using a random peptide library. Clin Immunol Immunopathol 1995; 75(1):45-50.
65. Dybwad A, Forre O, Sioud M. Increased serum and synovial fluid antibodies to immunoselected peptides in patients with rheumatoid arthritis. Ann Rheum Dis 1996; 55(7): 437-41.
66. Sioud M, Dybwad A, Jespersen L, Suleyman S, Natvig JB, Forre O. Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF-alpha): in vitro function and precise epitope mapping by phage epitope library. Clin Exp Immunol 1994; 98(3):520-5.
67. Matsushita S, Nishi T, Oiso M, Yamaoka K, Yone K, Kanai T, et al. HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes. Int Immunol 1996; 8(5):757-64.
68. Zhang M, Davidson A. A rheumatoid factor specific mimotope identified by a peptide display library. Autoimmunity 1999; 30(3):131-42.
69. von Landenberg P, Rzepka R, Melchers I. Monoclonal autoantibodies from patients with autoimmune diseases: synovial fluid B lymphocytes of a patient with rheumatoid arthritis produced an IgG lambda antibody recognizing J-sequences of Ig kappa chains in a conformation-dependent way. Immunobiology 1999; 200(2):205-14.
70. von Landenberg P, von Landenberg C, Grundl M, Schmitz G, Scholmerich J, Melchers I. A new antigenic epitope localized within human kappa light chains specific for rheumatoid arthritis and systemic lupus erythematosus. J Autoimmun 1999; 13(1):83-7.
71. Hansen MH, Dybwad A, Forre O, Sioud M. Probing antinuclear antibody specificities by peptide phage display libraries. Clin Exp Rheumatol 2000; 18(4):465-72.
72. Lee L, Buckley C, Blades MC, Panayi G, George AJ, Pitzalis C. Identification of synovium-specific homing peptides by in vivo phage display selection. Arthritis Rheum 2002; 46(8):2109-20.
73. Cortese I, Tafi R, Grimaldi LM, Martino G, Nicosia A, Cortese R. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc Natl Acad Sci U S A 1996; 93(20):11063-7.
74. Dybwad A, Flrre O, Sioud M. Probing for cerebrospinal fluid antibody specificities by a panel of random peptide libraries. Autoimmunity 1997; 25(2):85-9.
75. Cortese I, Capone S, Tafi R, Grimaldi LM, Nicosia A, Cortese R. Identification of peptides binding to IgG in the CSF of multiple sclerosis patients. Mult Scler 1998; 4(1):31-6.
76. Cortese I, Capone S, Luchetti S, Grimaldi LM, Nicosia A, Cortese R. CSF-enriched antibodies do not share specificities among MS patients. Mult Scler 1998; 4(3):118-23.
77. Rand KH, Houck H, Denslow ND, Heilman KM. Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 65(1):48-55.
78. Rand KH, Houck H. Improved methods for the application of random peptide phage libraries to the study of the oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis. J Neurosci Methods 2000; 101(2):131-9.
79. Cortese I, Capone S, Luchetti S, Cortese R, Nicosia A. Cross-reactive phage-displayed mimotopes lead to the discovery of mimicry between HSV-1 and a brain-specific protein. J Neuroimmunol 2001;113(1):119-28.
80. Jolivet-Reynaud C, Perron H, Ferrante P, Becquart L, Dalbon P, Mandrand B. Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes. Clin Immunol 1999; 93(3):283-93.
81. Yu X, Gilden DH, Ritchie AM, Burgoon MP, Keays KM, Owens GP. Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library. J Neuroimmunol. 2006; 172(1-2):121-31.
82. Yu X, Owens GP, Gilden DH. Rapid and efficient identification of epitopes/mimotopes from random peptide libraries. J Immunol Methods 2006; 316(1-2):67-74.
83. Sibille P, Ternynck T, Nato F, Buttin G, Strosberg D, Avrameas A. Mimotopes of polyreactive anti-DNA antibodies identified using phage-display peptide libraries. Eur J Immunol 1997; 27(5):1221-8.
84. Gaynor B, Putterman C, Valadon P, Spatz L, Scharff MD, Diamond B. Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A 1997; 94(5):1955-60.
85. Putterman C, Diamond B. Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 1998; 188(1):29-38.
86. Putterman C, Deocharan B, Diamond B. Molecular analysis of the autoantibody response in peptide-induced autoimmunity. J Immunol 2000; 164(5):2542-9.
87. Beger E, Deocharan B, Edelman M, Erblich B, Gu Y, Putterman C. A peptide DNA surrogate accelerates autoimmune manifestations and nephritis in lupus-prone mice. J Immunol 2002; 168(7):3617-26.
88. Sharma A, Isenberg D, Diamond B. Studies of human polyclonal and monoclonal antibodies binding to lupus autoantigens and cross-reactive antigens. Rheumatology 2003; 42(3):453-63.
89. Sun Y, Fong KY, Chung MC, Yao ZJ. Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus. Int Immunol 2001; 13(2):223-32.
90. Dieker JW, Sun YJ, Jacobs CW, Putterman C, Monestier M, Muller S, et al. Mimotopes for lupus-derived anti-DNA and nucleosome-specific autoantibodies selected from random peptide phage display libraries: facts and follies. J Immunol Methods 2005; 296(1-2):83-93.
91. Zhang W, Reichlin M. A peptide DNA surrogate that binds and inhibits anti-dsDNA antibodies. Clin Immunol 2005; 117(3):214-20.
92. Martin F, Chan AC. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 2004; 20(5):517-27.
93. Silverman GJ, Carson DA. Roles of B cells in rheumatoid arthritis. Arthritis Res Ther 2003; 5(Suppl 4):S1-6.
94. Ruff RL, Lennon VA. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis. Ann Neurol 1998; 43(3):370-9.
95. Deroo S, Muller CP. Antigenic and immunogenic phage displayed mimotopes as substitute antigens: applications and limitations. Comb Chem High Throughput Screen 2001; 4(1):75-110.